Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Pentadecane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.48 |
| ▸ | CES2 | O00748 | 3/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetradecane SCHEMBL23186 | 1.00 | TP53 (0.54) | TP53TSHRTHRBCA1CA2 | |
| Sulfuric Acid SCHEMBL29238027 | 1.00 | TP53 (0.54) | TP53TSHRTHRBCA1CA2 | |
| Hexadecane SCHEMBL11418243 | 1.00 | TP53 (0.54) | TP53TSHRTHRBCA1CA2 | |
| Octane SCHEMBL1531331 | 1.00 | TP53 (0.54) | TP53TSHRTHRBCA1CA2 | |
| Decane SCHEMBL3962533 | 1.00 | TP53 (0.54) | TP53TSHRTHRBCA1CA2 | |
| Heptane SCHEMBL25209213 | 1.00 | TP53 (0.54) | TP53TSHRTHRBCA1CA2 | |
| Decane SCHEMBL13370386 | 1.00 | TP53 (0.54) | TP53TSHRTHRBCA1CA2 | |
| Sulfuric Acid SCHEMBL11415405 | 1.00 | TP53 (0.54) | TP53TSHRTHRBCA1CA2 | |
| Dodecane SCHEMBL21806102 | 1.00 | TP53 (0.54) | TP53TSHRTHRBCA1CA2 | |
| Dodecane SCHEMBL534861 | 1.00 | TP53 (0.54) | TP53TSHRTHRBCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024106407-A1 | COMPOSITION CONTAINING POLYMER PARTICLES AND PRODUCTION METHOD FOR COMPOSITION CONTAINING POLYMER PARTICLES | キリンホールディングス株式会社 | 2024-05-23 | — | — | WO | disclosed |
| US-11891494-B2 | Antimicrobial resin and coating material | KIRIN HOLDINGS KABUSHIKI KAISHA (JP) | 2024-02-06 | — | — | US | disclosed |
| EP-3760193-B9 | INTRACELLULAR DELIVERY VEHICLE | KIRIN HOLDINGS KK (JP) | 2023-11-01 | — | — | EP | disclosed |
| EP-3760193-B1 | INTRACELLULAR DELIVERY VEHICLE | KIRIN HOLDINGS KK (JP) | 2023-07-05 | — | — | EP | disclosed |
| US-11452697-B2 | Intracellular delivery vehicle | KIRIN HOLDINGS KABUSHIKI KAISHA (JP) | 2022-09-27 | — | — | US | disclosed |
| US-20210363323-A1 | ANTIMICROBIAL RESIN AND COATING MATERIAL | KIRIN HOLDINGS KABUSHIKI KAISHA (JP) | 2021-11-25 | — | — | US | disclosed |
| EP-3785541-A1 | ANTIMICROBIAL RESIN AND COATING MATERIAL | KIRIN HOLDINGS KABUSHIKI KAISHA (JP) | 2021-03-03 | — | — | EP | disclosed |
| EP-3760193-A1 | INTRACELLULAR DELIVERY VEHICLE | Kirin Holdings Kabushiki Kaisha (JP) | 2021-01-06 | — | — | EP | disclosed |
| US-20200309782-A1 | INTRACELLULAR DELIVERY VEHICLE | KIRIN HOLDINGS KABUSHIKI KAISHA (JP) | 2020-10-01 | — | — | US | disclosed |
| EP-3348648-B1 | INTRACELLULAR DELIVERY VEHICLE | KIRIN HOLDINGS KK (JP) | 2020-08-19 | — | — | EP | disclosed |
| US-10712346-B2 | Intracellular delivery vehicle | KIRIN HOLDINGS KABUSHIKI KAISHA (JP) | 2020-07-14 | — | — | US | disclosed |
| US-20190137503-A1 | INTRACELLULAR DELIVERY VEHICLE | KIRIN KABUSHIKI KAISHA (JP) | 2019-05-09 | — | — | US | disclosed |
| CN-108350479-A | INTRACELLULAR DELIVERY VEHICLE | 麒麟株式会社 | 2018-07-31 | — | — | CN | disclosed |
| EP-3348648-A1 | INTRACELLULAR DELIVERY VEHICLE | Kirin Kabushiki Kaisha (JP) | 2018-07-18 | — | — | EP | disclosed |
| EP-2514771-A1 | RESIN MODIFIER | Kao Corporation (JP) | 2012-10-24 | — | — | EP | disclosed |
| US-4235752-A | IMPROVED DISHWASHING COMPOSITIONS | LEVER BROTHERS COMPANY (US) | 1980-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210363323-A1 | ANTIMICROBIAL RESIN AND COATING MATERIAL | CROCC, CLASP1, CAD | TP53 4580/4885TSHR 4216/4885THRB 4278/4885 |
| US-10712346-B2 | Intracellular delivery vehicle | CHERP, ACTB, GOLT1B | TP53 110/4885TSHR 3357/4885THRB 2723/4885 |
| US-11452697-B2 | Intracellular delivery vehicle | CHERP, ACTB, GOLT1B | TP53 110/4885TSHR 3357/4885THRB 2723/4885 |
| US-20200309782-A1 | INTRACELLULAR DELIVERY VEHICLE | CHERP, ACTB, GOLT1B | TP53 110/4885TSHR 3357/4885THRB 2723/4885 |
| US-11891494-B2 | Antimicrobial resin and coating material | CROCC, CLASP1, CAD | TP53 4580/4885TSHR 4216/4885THRB 4278/4885 |
| US-20190137503-A1 | INTRACELLULAR DELIVERY VEHICLE | CHERP, ACTB, GOLT1B | TP53 110/4885TSHR 3357/4885THRB 2723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.